These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25964249)

  • 1. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.
    Brinton LA; Key TJ; Kolonel LN; Michels KB; Sesso HD; Ursin G; Van Den Eeden SK; Wood SN; Falk RT; Parisi D; Guillemette C; Caron P; Turcotte V; Habel LA; Isaacs CJ; Riboli E; Weiderpass E; Cook MB
    J Clin Oncol; 2015 Jun; 33(18):2041-50. PubMed ID: 25964249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
    James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
    Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
    J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal predictors of prostate cancer: a meta-analysis.
    Shaneyfelt T; Husein R; Bubley G; Mantzoros CS
    J Clin Oncol; 2000 Feb; 18(4):847-53. PubMed ID: 10673527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
    Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
    Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results.
    Brinton LA; Cook MB; McCormack V; Johnson KC; Olsson H; Casagrande JT; Cooke R; Falk RT; Gapstur SM; Gaudet MM; Gaziano JM; Gkiokas G; Guénel P; Henderson BE; Hollenbeck A; Hsing AW; Kolonel LN; Isaacs C; Lubin JH; Michels KB; Negri E; Parisi D; Petridou ET; Pike MC; Riboli E; Sesso HD; Snyder K; Swerdlow AJ; ; Trichopoulos D; Ursin G; van den Brandt PA; Van Den Eeden SK; Weiderpass E; Willett WC; Ewertz M; Thomas DB
    J Natl Cancer Inst; 2014 Mar; 106(3):djt465. PubMed ID: 24552677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.
    Mullooly M; Yang HP; Falk RT; Nyante SJ; Cora R; Pfeiffer RM; Radisky DC; Visscher DW; Hartmann LC; Carter JM; Degnim AC; Stanczyk FZ; Figueroa JD; Garcia-Closas M; Lissowska J; Troester MA; Hewitt SM; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2017 Jan; 19(1):8. PubMed ID: 28103902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Levels of Androgens, Estrogens, and Sex Hormone Binding Globulin and Risk of Primary Gastric Cancer in Chinese Men: A Nested Case-Control Study.
    Zhu Z; Chen Y; Ren J; Dawsey SM; Yin J; Freedman ND; Fan JH; Taylor PR; Liu Y; Qiao YL; Abnet CC
    Cancer Prev Res (Phila); 2021 Jun; 14(6):659-666. PubMed ID: 33766833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.
    Woolcott CG; Shvetsov YB; Stanczyk FZ; Wilkens LR; White KK; Caberto C; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Endocr Relat Cancer; 2010 Mar; 17(1):125-34. PubMed ID: 19903744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
    Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
    J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.
    Petrick JL; Hyland PL; Caron P; Falk RT; Pfeiffer RM; Dawsey SM; Abnet CC; Taylor PR; Weinstein SJ; Albanes D; Freedman ND; Gapstur SM; Bradwin G; Guillemette C; Campbell PT; Cook MB
    J Natl Cancer Inst; 2019 Jan; 111(1):34-41. PubMed ID: 29788475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.